Anticoagulation in Patients With COVID-19: Benefits and Risks
Decisions regarding anticoagulation therapy for patients with COVID-19 should take into account the risk for treatment-associated bleeding, including intracranial hemorrhage.
All articles by Amit Akirov, MD
Recommended Management of Cardiovascular Health in American Indians and Alaska Natives
A scientific statement from the American Heart Association outlines considerations for cardiovascular health in American Indian and Alaska Native populations.
Effects of Hypertension on Cognitive Function Following Stroke
The goal of this study was to investigate the associations between SBP, DBP, and antihypertensive medication use with cognitive function at 90 days after stroke.
How Does Gender-Affirming Hormone Treatment Affect the Metabolic Profile in Transgender Individuals?
Cross-sex hormone therapy may have a negative effect on lipid profile and glucose levels in transgender men but not in transgender women.
Statin Treatment Linked to Worse Glucose Homeostasis in Older Adults
Treatment with statins for cardiovascular risk reduction is associated with higher levels of insulin resistance in older community-dwelling adults.
Recommendations for Management of Ischemic Stroke in Adults With COVID-19
A panel prepared a comprehensive set of practice implications for clinicians caring for adults with acute ischemic stroke with confirmed or suspected of having COVID-19.
National Lipid Association Statement on Genetic Testing in Dyslipidemia
A scientific statement from the National Lipid Association outlines the implications of genetic testing in patients with dyslipidemia.
Obesity and Type 2 Diabetes Predispose Adolescents to Accelerated Vascular Aging
Adolescents with obesity or type 2 diabetes are at increased risk for progression of cardiovascular risk factors and accelerated early vascular aging.
Cardiovascular Safety of Fremanezumab in Patients With Migraine
Treatment with fremanezumab for episodic and chronic migraine was found to have a favorable cardiovascular safety profile in patients with and without a history of cardiovascular disease.
Benefits of Add-On Rivaroxaban in Patients With and Without Diabetes
Among patients with stable atherosclerosis, add-on rivaroxaban to aspirin therapy reduced cardiovascular events, whether or not they had diabetes.
-
Loading...
-
Loading...
Next post in Vascular Medicine
